For example, by attenuating the stability of mTOR, a kinase complex that phosphorylates AKT, palmitoylation of mTOR mediated by ZDHHC22 reduced AKT signaling in breast cancer cells [65]. This evidence concerns the gene AKT1 and breast cancer.